Christopher J. Mcdougle
#172,264
Most Influential Person Across History
Christopher J. Mcdougle's AcademicInfluence.com Rankings
Download Badge
Philosophy Biology
Christopher J. Mcdougle's Degrees
- Masters Medicine Harvard University
- PhD Neuroscience Harvard University
Why Is Christopher J. Mcdougle Influential?
(Suggest an Edit or Addition)Christopher J. Mcdougle's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Functional impact of global rare copy number variation in autism spectrum disorders (2010) (1891)
- Autism genome-wide copy number variation reveals ubiquitin and neuronal genes (2009) (1364)
- Risperidone in children with autism and serious behavioral problems. (2002) (1186)
- Symptoms of obsessive-compulsive disorder. (1997) (744)
- A genome-wide scan for common alleles affecting risk for autism (2010) (567)
- Parent-Rated Anxiety Symptoms in Children with Pervasive Developmental Disorders: Frequency and Association with Core Autism Symptoms and Cognitive Functioning (2008) (558)
- Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. (1994) (549)
- Family accommodation in obsessive-compulsive disorder. (1995) (526)
- A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. (1996) (517)
- Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. (2005) (486)
- A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. (2000) (484)
- Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. (2005) (406)
- A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. (1998) (377)
- Individual common variants exert weak effects on the risk for autism spectrum disorders (2012) (346)
- Tryptophan Depletion During Continuous CSF Sampling in Healthy Human Subjects (1998) (311)
- A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. (1995) (304)
- Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. (2009) (294)
- Effects of tryptophan depletion in drug-free adults with autistic disorder. (1996) (290)
- Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? (1990) (261)
- Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. (2003) (260)
- Synergistic Action of 5-HT2A Antagonists and Selective Serotonin Reuptake Inhibitors in Neuropsychiatric Disorders (2003) (258)
- Tic-related vs. non-tic-related obsessive compulsive disorder. (1994) (258)
- Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. (1990) (235)
- Gastrointestinal Symptoms in a Sample of Children with Pervasive Developmental Disorders (2009) (227)
- Pharmacotherapy for Posttraumatic Stress Disorder Using Phenelzine or Imipramine (1991) (224)
- Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study. (1999) (216)
- Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study. (1997) (214)
- [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. (1995) (210)
- Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months. (2005) (205)
- Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls. (1994) (198)
- Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials. (2003) (194)
- A pilot study of D-cycloserine in subjects with autistic disorder. (2004) (193)
- The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. (1993) (192)
- Structural and functional magnetic resonance imaging of autism spectrum disorders (2011) (188)
- Obsessive–Compulsive Disorder with and without a Chronic Tic Disorder (1994) (188)
- A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder (2011) (186)
- Cerebrospinal Fluid Corticotropin-Releasing Factor and Perceived Early-Life Stress in Depressed Patients and Healthy Control Subjects (2004) (176)
- Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. (1991) (172)
- Exploring the Manifestations of Anxiety in Children with Autism Spectrum Disorders (2013) (172)
- Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. (2006) (171)
- Antipsychotics in the treatment of autism. (2008) (169)
- Cerebrospinal Fluid Biogenic Amines in Obsessive Compulsive Disorder, Tourette's Syndrome, and Healthy Controls (1995) (168)
- A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy. (1991) (168)
- High nitric oxide production in autistic disorder: a possible role for interferon-γ (2004) (167)
- Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone. (2000) (164)
- Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report. (1995) (156)
- Gastrointestinal Factors in Autistic Disorder: A Critical Review (2005) (156)
- Case series: use of ziprasidone for maladaptive symptoms in youths with autism. (2002) (151)
- The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. (1992) (150)
- Acute and long-term safety and tolerability of risperidone in children with autism. (2005) (150)
- Onset and exacerbation of obsessive-compulsive disorder in pregnancy and the postpartum period. (2010) (145)
- Validity of the autism diagnostic interview-revised. (2006) (145)
- Sensory symptoms in autism spectrum disorders. (2014) (143)
- Effects of Short- and Long-Term Risperidone Treatment on Prolactin Levels in Children with Autism (2007) (142)
- A retrospective study of memantine in children and adolescents with pervasive developmental disorders (2007) (140)
- High blood monocyte counts and neopterin levels in children with autistic disorder. (2003) (138)
- Sertraline in adults with pervasive developmental disorders: a prospective open-label investigation. (1998) (133)
- Positive Effects of Methylphenidate on Social Communication and Self-Regulation in Children with Pervasive Developmental Disorders and Hyperactivity (2009) (133)
- Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors. (1994) (132)
- Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial. (2009) (128)
- Clomipramine in autism: preliminary evidence of efficacy. (1992) (127)
- The role of central oxytocin in obsessive compulsive disorder and related normal behavior (1994) (127)
- Positive Effects of Methylphenidate on Inattention and Hyperactivity in Pervasive Developmental Disorders: An Analysis of Secondary Measures (2007) (127)
- Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder. (2015) (123)
- Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data. (2004) (122)
- Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases. (1995) (119)
- Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases. (2004) (117)
- Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. (2008) (116)
- Assessment in Multisite Randomized Clinical Trials of Patients with Autistic Disorder: The Autism RUPP Network (2000) (115)
- Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. (2006) (115)
- Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder. (1993) (115)
- Weight Gain Associated with Atypical Antipsychotic Use in Children and Adolescents (2004) (113)
- A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders. (2001) (113)
- Gender differences in response to intranasal cocaine administration to humans (1996) (113)
- The association between self-injurious behaviors and autism spectrum disorders (2014) (111)
- Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder. (1995) (111)
- A prospective open trial of guanfacine in children with pervasive developmental disorders. (2006) (110)
- The Pharmacotherapy of Target Symptoms Associated with Autistic Disorder and Other Pervasive Developmental Disorders (2000) (109)
- Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan (2012) (108)
- Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder. (2008) (106)
- Aripiprazole for maladaptive behavior in pervasive developmental disorders. (2004) (106)
- Repetitive Thoughts and Behavior in Pervasive Developmental Disorders: Treatment with Serotonin Reuptake Inhibitors (2000) (104)
- Clomipramine in adults with pervasive developmental disorders: a prospective open-label investigation. (1997) (101)
- Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series. (1999) (100)
- Brief Report: Autistic Disorder in Three Children with Cytomegalovirus Infection (2004) (100)
- The amygdala and related structures in the pathophysiology of autism (2002) (100)
- Psychopharmacological interventions in autism spectrum disorder (2016) (100)
- Noradrenergic dysregulation during discontinuation of cocaine use in addicts. (1994) (99)
- Effects of acute tryptophan depletion on nocturnal melatonin secretion in humans. (1993) (97)
- Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene (2005) (96)
- Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study. (2009) (96)
- Biological approaches to treatment-resistant obsessive compulsive disorder. (1993) (94)
- Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome (2013) (92)
- Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors. (2000) (89)
- A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders. (2004) (89)
- Risperidone and adaptive behavior in children with autism. (2006) (88)
- Neurochemistry in the pathophysiology of autism. (2005) (85)
- The pharmacotherapy of obsessive-compulsive disorder. (1992) (85)
- Intranasal oxytocin in obsessive-compulsive disorder (1996) (84)
- Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders (2014) (84)
- Possible role of neuropeptides in obsessive compulsive disorder (1999) (83)
- A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder (2016) (82)
- Elevated cerebrospinal fluid corticotropin-releasing ractor in Tourette's syndrome: Comparison to obsessive compulsive disorder and normal controls (1996) (81)
- Development of a parent training program for children with pervasive developmental disorders (2007) (81)
- Toward an immune-mediated subtype of autism spectrum disorder (2015) (80)
- Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems. (2012) (79)
- A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders. (2004) (78)
- m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: Absence of symptom exacerbation (1995) (78)
- Maternal and early postnatal immune activation produce sex-specific effects on autism-like behaviors and neuroimmune function in mice (2019) (78)
- Treatment of aggression in children and adolescents with autism and conduct disorder. (2003) (77)
- Trichotillomania. Presentation, etiology, diagnosis and therapy. (2001) (77)
- Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: A chart review study (2015) (76)
- Brief Report: Acamprosate in Fragile X Syndrome (2010) (75)
- The use of selective serotonin reuptake inhibitors in autism and related disorders. (2006) (74)
- From anxiety to autism: spectrum of abnormal social behaviors modeled by progressive disruption of inhibitory neuronal function in the basolateral amygdala in Wistar rats (2007) (73)
- The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis. (1993) (72)
- Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder. (2021) (72)
- Open-label riluzole in fragile X syndrome (2011) (71)
- Multidisciplinary Assessment and Treatment of Self-Injurious Behavior in Autism Spectrum Disorder and Intellectual Disability: Integration of Psychological and Biological Theory and Approach (2015) (70)
- Developmental Disabilities Modification of the Children’s Global Assessment Scale (2007) (70)
- Update on pharmacologic management of OCD: agents and augmentation. (1997) (70)
- A systematic review of molecular imaging (PET and SPECT) in autism spectrum disorder: Current state and future research opportunities (2015) (69)
- Sertraline and breast-feeding. (1997) (67)
- Pharmacologic Treatment of Behavioral Symptoms Associated With Autism and Other Pervasive Developmental Disorders (2010) (66)
- Pharmacotherapeutic management of autism (2001) (66)
- Developing drugs for core social and communication impairment in autism. (2008) (66)
- Risperidone in the treatment of two very young children with autism. (1999) (65)
- Open-Label Memantine in Fragile X Syndrome (2009) (64)
- Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial. (2015) (63)
- Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: A case report (1990) (62)
- Communication Deficits and the Motor System: Exploring Patterns of Associations in Autism Spectrum Disorder (ASD) (2017) (62)
- A comparison of trazodone and fluoxetine: implications for a serotonergic mechanis of antidepressant action (2005) (61)
- The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder (1992) (61)
- Paliperidone for irritability in adolescents and young adults with autistic disorder (2012) (61)
- A prospective open-label study of aripiprazole in fragile X syndrome (2011) (61)
- Cognitive effects of risperidone in children with autism and irritable behavior. (2008) (60)
- Paroxetine in autism. (1999) (59)
- The Neurobiology of Tryptophan Depletion in Depression: Effects of Intravenous Tryptophan Infusion (1998) (59)
- An exploration of concomitant psychiatric disorders in children with autism spectrum disorder. (2019) (59)
- Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability. (2010) (58)
- Children's Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklist. (2014) (58)
- Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder. (2016) (58)
- Tolerability Profile of Atypical Antipsychotics in Children and Adolescents (2001) (57)
- Pharmacotherapy of irritability in pervasive developmental disorders. (2008) (57)
- Autism and immune factors: A comprehensive review (2009) (57)
- Dietary status and impact of risperidone on nutritional balance in children with autism: A pilot study (2006) (56)
- Aripiprazole in autism spectrum disorders and fragile X syndrome (2010) (56)
- Limited efficacy of ketoconazole in treatment-refractory major depression. (1999) (55)
- Global functioning of inpatients with obsessive-compulsive disorder, schizophrenia, and major depression. (1998) (55)
- Women and Autism Spectrum Disorder: Diagnosis and Implications for Treatment of Adolescents and Adults (2019) (55)
- Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies (2013) (54)
- Serotonergic mechanisms of cocaine effects in humans (1995) (54)
- Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects. (1994) (54)
- An open-label naturalistic pilot study of acamprosate in youth with autistic disorder. (2011) (53)
- Acute tryptophan depletion in autistic disorder: A controlled case study (1993) (52)
- Pharmacotherapy to control behavioral symptoms in children with autism (2012) (52)
- Neurobiology of Tryptophan Depletion in Depression: Effects of m-Chlorophenylpiperazine (mCPP) (1997) (50)
- A randomized, placebo-controlled trial of d-cycloserine for the enhancement of social skills training in autism spectrum disorders (2016) (50)
- Maternal and Early Postnatal Immune Activation Produce Dissociable Effects on Neurotransmission in mPFC–Amygdala Circuits (2018) (50)
- Overweight and obese status in children with autism spectrum disorder and disruptive behavior (2018) (49)
- Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems. (2014) (49)
- Brief Report: Social Disability in Autism Spectrum Disorder: Results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network Trials (2013) (48)
- Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder. (1997) (48)
- Brief Report: Bone Fractures in Children and Adults with Autism Spectrum Disorders (2015) (47)
- Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker. (2014) (46)
- An open trial of fluoxetine in the treatment of posttraumatic stress disorder. (1991) (46)
- Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years. (2010) (45)
- Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism. (2001) (45)
- Antiglucocorticoid treatment of refractory depression with ketoconazole: A case report (1995) (44)
- A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures (2018) (44)
- Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder. (1994) (44)
- Cerebrospinal fluid interleukin-6 in obsessive–compulsive disorder and trichotillomania (2002) (43)
- Psychopharmacological Interventions in Autism Spectrum Disorder (2014) (43)
- Factor structure and psychometric properties of the revised Home Situations Questionnaire for autism spectrum disorder: The Home Situations Questionnaire-Autism Spectrum Disorder (2016) (43)
- Body mass index change in autism spectrum disorders: comparison of treatment with risperidone and aripiprazole. (2014) (41)
- The Home Situations Questionnaire-PDD version: factor structure and psychometric properties. (2010) (41)
- Risperidone in Adults with Autism or Pervasive Developmental Disorder (1995) (40)
- Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders (2013) (40)
- A Double-Blind, Placebo-Controlled Trial of Oral Human Immunoglobulin for Gastrointestinal Dysfunction in Children with Autistic Disorder (2009) (40)
- Trial Design Challenges When Combining Medication and Parent Training in Children with Pervasive Developmental Disorders (2009) (40)
- Nutrition and Bone Density in Boys with Autism Spectrum Disorder. (2018) (38)
- Obsessions and compulsions associated with cocaine abuse. (1991) (38)
- Sex-dependent neurobiological features of prenatal immune activation via TLR7 (2019) (38)
- Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania: three cases. (1999) (37)
- Noradrenergic response to acute ethanol administration in heathly subjects: comparison with intravenous yohimbine (1995) (36)
- A Pilot Study of Autism-Specific Care Plans During Hospital Admission (2016) (35)
- Ramelteon for insomnia in two youths with autistic disorder. (2006) (35)
- Research Units of Pediatric Psychopharmacology (RUPP) autism network randomized clinical trial of parent training and medication: one-year follow-up. (2012) (35)
- Pharmacotherapy of obsessive compulsive disorder. (1993) (34)
- Obsessive-compulsive disorder (OCD). (2005) (34)
- Spect regional cerebral blood flow and neuropsychological testing in non-demented HIV-positive drug abusers: Preliminary results (1991) (34)
- Research knowledge among parents of children participating in a randomized clinical trial. (2005) (33)
- Effects of Acute Tryptophan Depletion in Lithium-Remitted Manic Patients: A Pilot Study (1997) (33)
- Yohimbine augmentation of fluvoxamine in refractory depression: A single-blind study (1995) (33)
- Attention-Deficit and Disruptive Behavior Disorders (2014) (33)
- Recent Advances in the Pharmacotherapy of Autism and Related Conditions (1994) (32)
- Double-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorder. (2013) (32)
- Speech and language in autism spectrum disorder: a view through the lens of behavior and brain imaging (2013) (32)
- Potential of Atypical Antipsychotics in the Treatment of Nonpsychotic Disorders (1998) (31)
- Olanzapine augmentation of fluoxetine in the treatment of trichotillomania. (1998) (30)
- Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study (2007) (29)
- Dopaminergic responsivity during cocaine abstinence: a pilot study (1992) (29)
- Genetics of childhood disorders: XLIV. autism, part 3: psychopharmacology of autism. (2002) (29)
- Emerging drugs for the treatment of symptoms associated with autism spectrum disorders (2010) (29)
- Brief Report: Two-Year Control of Behavioral Symptoms with Risperidone in Two Profoundly Retarded Adults with Autism (1999) (29)
- d-Cycloserine enhances durability of social skills training in autism spectrum disorder (2017) (28)
- Riluzole in autistic disorder. (2011) (28)
- The Role of Serotonin in Autism-Spectrum Disorders (1997) (28)
- Perinatal Immune Activation Produces Persistent Sleep Alterations and Epileptiform Activity in Male Mice (2018) (28)
- Paliperidone for irritability in autistic disorder. (2010) (28)
- Beyond the brain: A multi-system inflammatory subtype of autism spectrum disorder (2019) (28)
- Guanfacine and guanfacine extended release: treatment for ADHD and related disorders. (2007) (27)
- Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13. (2011) (26)
- Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity. (2010) (26)
- Pathophysiology of obsessive-compulsive disorder. (1989) (26)
- Brief Report: Autism Spectrum Disorder and Substance Use Disorder: A Review and Case Study (2016) (26)
- Pharmacology of autism (2006) (25)
- Urinary 6-hydroxymelatonin sulfate as a measure of melatonin secretion during acute tryptophan depletion (1993) (25)
- [11C]PBR28 MR–PET imaging reveals lower regional brain expression of translocator protein (TSPO) in young adult males with autism spectrum disorder (2020) (24)
- Clinical Correlates of Parenting Stress in Children with Autism Spectrum Disorder and Serious Behavioral Problems (2019) (24)
- Intramuscular ziprasidone for acute agitation in adolescents. (2004) (24)
- Sleep as a translationally-relevant endpoint in studies of autism spectrum disorder (ASD) (2019) (24)
- Brief Report: Pilot Single-Blind Placebo Lead-In Study of Acamprosate in Youth with Autistic Disorder (2014) (23)
- Pharmacotherapy of Down syndrome (2018) (23)
- Pharmacologic treatment of autism and related disorders. (2007) (23)
- Antiglucocorticoids as Treatments for Depression (1996) (23)
- Paliperidone palmitate in a child with autistic disorder. (2011) (23)
- Predictors and Moderators of Parent Training Efficacy in a Sample of Children with Autism Spectrum Disorders and Serious Behavioral Problems (2012) (23)
- A Retrospective Naturalistic Study of Ziprasidone for Irritability in Youth with Autism Spectrum Disorder. (2015) (23)
- Differences in verbal and nonverbal IQ test scores in children with autism spectrum disorder (2018) (23)
- Pharmacological augmentation strategies for treatment-resistant obsessive-compulsive disorder (2004) (22)
- Bone microarchitecture in adolescent boys with autism spectrum disorder. (2017) (22)
- Psychiatric Disorder (2020) (22)
- Multiple Antipsychotic Medication Use in Autism Spectrum Disorder. (2017) (22)
- Rapid clinical deterioration in an individual with Down syndrome (2016) (21)
- Phenotypic differences in individuals with autism spectrum disorder born preterm and at term gestation (2015) (21)
- Effects of Antiglucocorticoid Treatment on 5-HT1A Function in Depressed Patients and Healthy Subjects (1997) (20)
- Seasonal Variation in Neuroendocrine and Mood Responses to IV L-Tryptophan in Depressed Patients and Healthy Subjects (1996) (20)
- Increased cerebrospinal fluid corticotropin-releasing factor concentrations during tryptophan depletion in healthy adults (2004) (20)
- Olanzapine augmentation of fluoxetine in the treatment of refractory obsessive-compulsive disorder. (1998) (20)
- Changes in the diagnostic criteria for autism in DSM-5: controversies and concerns. (2013) (20)
- The effects of aripiprazole on electrocardiography in children with pervasive developmental disorders. (2012) (19)
- Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study (1998) (19)
- Evidence-Based Treatments for Autism Spectrum Disorder (2015) (19)
- Bone Accrual in Males with Autism Spectrum Disorder (2017) (18)
- Standardised Observation Analogue Procedure (SOAP) for assessing parent and child behaviours in clinical trials (2009) (18)
- A Protocol for Sedation Free MRI and PET Imaging in Adults with Autism Spectrum Disorder (2019) (18)
- Psychotherapy and medication management strategies for obsessive-compulsive disorder (2011) (18)
- Using a Patient-Centered Outcome Measure to Test Methylphenidate Versus Placebo in Children with Autism Spectrum Disorder. (2017) (17)
- Risperidone in pervasive developmental disorders (2005) (17)
- Attention Bias to Emotional Faces Varies by IQ and Anxiety in Williams Syndrome (2016) (17)
- IQSEC2 and X-linked syndromal intellectual disability (2016) (17)
- A Risk-Benefit Assessment of Drugs Used in the Management of Obsessive-Compulsive Disorder (1996) (17)
- Case Report: 16-Year-Old Male with Autistic Disorder with Preoccupation with Female Feet (2012) (17)
- Use of a Direct Observational Measure in a Trial of Risperidone and Parent Training in Children with Pervasive Developmental Disorders (2013) (16)
- Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine (2005) (16)
- Pharmacotherapy of Autism and Related Disorders (2007) (16)
- Treatment of Folate Metabolism Abnormalities in Autism Spectrum Disorder (2020) (16)
- Lithium Augmentation of Fluvoxamine in Autistic Disorder: A Case Report (1994) (15)
- Assessment of diurnal variation of cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in healthy human females. (1997) (15)
- Sounding a wake-up call: improving the lives of adults with autism. (2013) (15)
- Autism and Pervasive Developmental Disorders: Psychopharmacology (2007) (14)
- Effects of catecholamine depletion with AMPT (alpha-methyl-para-tyrosine) in obsessive-compulsive disorder (1999) (14)
- Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes. (2015) (13)
- Recent advances in the pharmacotherapy of autism (2002) (13)
- The pathophysiology and treatment of autism (2001) (13)
- Priapism associated with trazodone in an adolescent with autism. (2002) (13)
- Accuracy of self-reported history of autoimmune disease: A pilot study (2019) (13)
- Pharmacotherapy of Behavioral Symptoms and Psychiatric Comorbidities in Adolescents and Adults with Autism Spectrum Disorders (2014) (13)
- Baclofen-assisted detoxification from opiates. A pilot study. (1992) (13)
- Substance dependence. (1998) (13)
- Neurodevelopmental Disorders Among Publicly or Privately Insured Children in the United States. (2022) (12)
- Co-Morbid Intellectual Disability and Borderline Personality Disorder: A Case Series (2010) (12)
- Neuroinflammation and Autism: Toward Mechanisms and Treatments (2013) (12)
- Assessment of Speech and Fine Motor Coordination in Children With Autism Spectrum Disorder (2020) (12)
- Structural and Functional MRI Studies of Autism Spectrum Disorders (2013) (12)
- Olanzapine versus placebo in adolescents with schizophrenia (2007) (12)
- Predictors of Caregiver Strain for Parents of Children with Autism Spectrum Disorder (2020) (11)
- Rationale, design, and methods of the autism centers of excellence (ACE) network study of oxytocin in autism to improve reciprocal social behaviors (SOARS-B). (2020) (11)
- Epigenetics of Autism Spectrum Disorder: Histone Deacetylases (2021) (11)
- Pharmacological strategies for trichotillomania (2005) (11)
- Mobile device applications and treatment of autism spectrum disorder: a systematic review and meta-analysis of effectiveness (2019) (11)
- Developmental Disabilities Modification of Children’s Global Assessment Scale (DD-CGAS) psychometrics (2007) (11)
- CURRENT AND EMERGING THERAPEUTICS OF AUTISTIC DISORDER AND RELATED PERVASIVE DEVELOPMENTAL DISORDERS (2002) (11)
- Iron homeostasis during risperidone treatment in children and adolescents. (2015) (10)
- Maternal folic acid supplementation and risk of autism. (2013) (10)
- Induction of indoleamine 2,3-dioxygenase in vivo by IFN-con1. (2001) (10)
- Sleeplessness (1885) (10)
- Obsessive-compulsive disorder: recent neurobiological developments (1990) (10)
- It Is Time to Take a Stand for Medical Research and Against Terrorism Targeting Medical Scientists (2008) (9)
- Sensitivity of the modified Children’s Yale–Brown Obsessive Compulsive Scale to detect change: Results from two multi-site trials (2016) (9)
- Acute tryptophan depletion in schizophrenic patients treated with clozapine. (2002) (9)
- Mentorship of Clinical-Track Junior Faculty: Impact of a Facilitated Peer-Mentoring Program to Promote Scholarly Productivity (2013) (9)
- Obsessive-compulsive symptoms with-neuroleptics. (1996) (9)
- Tactile Defensiveness and Discrimination Test-Revised (2021) (9)
- Ziprasidone treatment of two adolescents with psychosis. (2004) (8)
- Buspirone for the treatment of anxiety-related symptoms in Angelman syndrome: a case series (2019) (8)
- Advances in the Pharmacotherapy of Pervasive Developmental Disorders (PDD) (2003) (8)
- ECT in an Adolescent with Down Syndrome and Treatment-Refractory Major Depressive Disorder (2002) (8)
- Abnormal Involuntary Movement Scale (2021) (7)
- Risperidone: a potential treatment for autism. (2002) (7)
- Emergence of an alternate personality in combat-related posttraumatic stress disorder. (1990) (7)
- A randomized double-blind, placebo-controlled pilot trial of mirtazapine for anxiety in children and adolescents with autism spectrum disorder (2022) (7)
- Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Adults with Down Syndrome: A Preliminary Retrospective Chart Review Study (2021) (6)
- Assessment of the Integrity of Study Blindness in a Pediatric Clinical Trial of Risperidone (2005) (6)
- Serotonin Reuptake Inhibitors in the Treatment of Obsessive-Compulsive Disorder (1990) (6)
- Challenges in the Medical Care of Patients With Autism Spectrum Disorder: The Role of the Consultation-Liaison Psychiatrist. (2019) (6)
- Agitation in Patients With Autism Spectrum Disorder Admitted to Inpatient Pediatric Medical Units (2020) (6)
- Guanfacine extended release in two patients with pervasive developmental disorders. (2011) (6)
- Plasma Kynurenine Levels in Autistic Disorder (2006) (6)
- Memantine for comorbid obsessive-compulsive disorder and Asperger disorder suggests a link in glutamatergic dysregulation. (2011) (6)
- 0466 RESULTS FROM A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF OLANZAPINE IN ADOLESCENTS WITH SCHIZOPHRENIA (2006) (6)
- Tourette's disorder and associated complex behaviors: a case report. (1990) (6)
- Characterization of sleep habits and medication outcomes for sleep disturbance in children and adults with Angelman syndrome (2020) (6)
- Comparison of Services for Autism Spectrum Disorder in Massachusetts with Those in Seoul (2019) (5)
- Acute onset of obsessive-compulsive disorder in an adolescent with acute lymphoblastic leukemia. (2005) (5)
- Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder (2021) (5)
- Buspirone for the Treatment of Generalized Anxiety Disorder in Williams Syndrome: A Case Series (2019) (5)
- No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder. (2015) (5)
- Beware of Over-Interpreting Negative Trials (2008) (5)
- Association of Antipsychotic Drug Exposure in Pregnancy With Risk of Neurodevelopmental Disorders: A National Birth Cohort Study. (2022) (5)
- N-Acetylcysteine for Neuropsychiatric Symptoms in a Woman With Williams Syndrome (2014) (5)
- Pharmacological management of agitation and aggression in an adolescent with autism. (2005) (5)
- Use of Atypical Antipsychotics in Autism (2003) (5)
- Another Step Toward Defining an Immune-Mediated Subtype of Autism Spectrum Disorder. (2018) (5)
- Psychiatric Assessment of Social Impairment Across the Lifespan. (2020) (4)
- Treatment of Tourette's Syndrome (2008) (4)
- Association of Antidepressant Use During Pregnancy With Risk of Neurodevelopmental Disorders in Children. (2022) (4)
- Psychopharmacology of Williams syndrome: safety, tolerability, and effectiveness (2020) (4)
- Brief Report: Major Depressive Disorder with Psychotic Features in Williams Syndrome: A Case Series (2018) (4)
- Fraternal Twins (1938) (4)
- Immune Modulatory Treatments for Autism Spectrum Disorder. (2020) (4)
- Evaluation of Sensory Processing (2021) (4)
- Current state and future prospects of pharmacological interventions for autism (2013) (4)
- Buspirone for bruxism in a child with pervasive developmental disorder-not otherwise specified. (2011) (4)
- Providing Inpatient Medical Care to Children With Autism Spectrum Disorder. (2020) (4)
- Serotonin and dopamine transporter binding in children with autism (2008) (4)
- Reply to comments on "Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study". (2001) (4)
- The Pharmacotherapy of Treatment-Resistant Obsessive-Compulsive Disorder (1992) (4)
- Recent Updates in Psychopharmacology for the Core and Associated Symptoms of Autism Spectrum Disorder (2021) (4)
- Recent progress in autism spectrum disorder (2013) (3)
- MIRTAZAPINE TREATMENT OF ANXIETY IN CHILDREN AND ADOLESCENTS WITH PERVASIVE DEVELOPMENTAL DISORDERS (2018) (3)
- Neurobiology of Serotonin Function in Autism (2003) (3)
- Neural targets in the study and treatment of social cognition in autism spectrum disorder. (2015) (3)
- Sleep and EEG biomarkers as avenues toward new treatment approaches in Angelman syndrome (2019) (3)
- Personality: Neurobehavioural Foundation and Pharmacological Protocols (2014) (3)
- Case Reports: Clozapine for the Treatment of Catatonia in Autism Spectrum Disorder (2021) (3)
- Repetitive Thoughts and Repetitive Behaviors in Williams Syndrome (2021) (2)
- Affective State (2020) (2)
- Parent Description of Anxiety in Angelman Syndrome (2021) (2)
- Methylphenidate an effective treatment for ADHD? (2004) (2)
- Psychopharmacology of autism (1998) (2)
- Assessment and Treatment of Autistic and Other Pervasive Developmental Disorders (2010) (2)
- Post-traumatic stress disorder following cardiac surgery: A case report of a nine-year-old female with Williams syndrome (2019) (2)
- Behavioral Facilitation (2006) (2)
- Developmental Disability--Children's Global Assessment Scale (2015) (2)
- Gender Differences in Treatment-Seeking Youth with Autism Spectrum Disorder (2021) (2)
- Atypical Antipsychotic-Induced Weight Gain in Children and Adolescents: Sometimes Less Is More. (2016) (2)
- Constance E. Lieber, Theodore R. Stanley, and the Enduring Impact of Philanthropy on Psychiatry Research (2016) (2)
- Home Situations Questionnaire--Autism Spectrum Disorder (2016) (2)
- Paroxetine: a new serotonin reuptake inhibitor for the treatment of depression. (1993) (2)
- Special issue on autism spectrum disorders. Introduction. (2014) (1)
- Brief Report: Autism Spectrum Disorder and Substance Use Disorder: A Review and Case Study (2016) (1)
- P.2.109 A double-blind placebo-controlled trial of risperidone in autistic disorder (2003) (1)
- 5.9 Evaluating the Relationship Between the Vineland Adaptive Behavior Scale and the Assessment of Basic Language and Learning Skills-Modified (2017) (1)
- Case Report: 16-Year-Old Male with Autistic Disorder with Preoccupation with Female Feet (2011) (1)
- Dr. Aman et al. reply (2010) (1)
- Psychopharmacological Treatment of Autism (2011) (1)
- Pediatric psychopharmacology: mood, anxiety and disruptive behavior/pervasive developmental disorders (2007) (1)
- New research on the neurobiology of obsessive—compulsive disorder (1992) (1)
- Neurodevelopmental Disorders: Communication Disorders (2015) (1)
- Psychopharmacologic treatment of children prenatally exposed to drugs of abuse (2015) (1)
- Cerebrospinal Fluid Oxytocin Levels in Trichotillomania (1998) (1)
- Attention Deficit Hyperactivity Disorders: Animal Models (2014) (1)
- Treating autism spectrum disorders (2008) (1)
- Secretin in autism--a parent's perspective. (2000) (1)
- Adaptive Behavior in Young Autistic Children: Associations with Irritability and ADHD Symptoms. (2022) (1)
- Phase II and III drugs for the treatment of fragile X syndrome (2013) (1)
- New-Onset Abnormal Vocalizations in an Adult Woman With Down Syndrome. (2020) (1)
- A possible role of dopamine in some forms of obsessive compulsive disorder (1991) (1)
- 407. Controlled study of antidepressant treatment of postpartum depression (1996) (1)
- Family Accommodation Scale (2014) (1)
- Developmental Apraxia of Speech (DAS) (2021) (1)
- Help for the child with autism. (2013) (1)
- Immunological Aspects of Autism Spectrum Disorder (2015) (1)
- Fragile X syndrome (2017) (1)
- Topiramate for weight loss in two young adult women with autism spectrum disorder. (2015) (1)
- Obsessive–Compulsive Disorder (2014) (1)
- OBSESSIVE-COMPULSIVE SYMPTOMS WITH NEUROLEPTICS. AUTHORS REPLY (1996) (1)
- Ask the Editor (2005) (1)
- Antipsychotic Drugs in Children and Adolescents (1996) (1)
- Hyperkinetic Disorders (2020) (1)
- Beyond the serotonin hypothesis of OCD (1993) (1)
- Buspirone for the Treatment of Generalized Anxiety Disorder in Down Syndrome: 3 Cases (2021) (1)
- 290. Altered Behavior, Sleep, and Epileptiform Activity in a Perinatal Multiple Hit Immune Activation Mouse Model of Autism Spectrum Disorder (ASD) (2017) (1)
- Stimulant intolerance in children with Angelman syndrome with hyperactivity: a case series (2021) (1)
- Obsessive-Compulsive Disorder Reconsidered (1988) (1)
- PHENELZINE OR IMIPRAMINE IN POSTTRAUMATIC STRESS DISORDER (1992) (1)
- Risk Factors for Self-injurious Behavior in an Inpatient Psychiatric Sample of Children with Autism Spectrum Disorder: A Naturalistic Observation Study (2018) (1)
- Pimozide (2021) (0)
- Genetic and epigenetic signatures associated with plasma oxytocin levels in children and adolescents with autism spectrum disorder (2022) (0)
- Serotonin Reuptake Inhibitors (SRIs) (2021) (0)
- 6.7 Cannabis-Induced Mania and Psychosis in Young Adult Males With Autism Spectrum Disorder: A Case Series and Literature Review (2021) (0)
- 1.3 Psychopharmacology of ASD (2018) (0)
- Repetitive Thoughts and Behaviors in Autism Spectrum Disorder: A Symptom-Based Framework for Novel Therapeutics. (2023) (0)
- 6.0 Understanding Comorbid Symptom Dimensions in Autism Spectrum Disorder (2017) (0)
- Obsessive-compulsive disorder (OCD) may represent a syndrome with multiple aetiologies rather than a homogeneous disease entity. One putative subgroup of OCD is composed of those OCD patients with a lifetime history of tic symptoms (Tourette's syndrome (2006) (0)
- Beyond the brain: A multi-system inflammatory subtype of autism spectrum disorder (2019) (0)
- Serotonin Syndrome (2022) (0)
- Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder (2017) (0)
- When SSRIs make sense (2000) (0)
- MHPG, ECT, and depression (1985) (0)
- Communication Deficits and the Motor System: Exploring Patterns of Associations in Autism Spectrum Disorder (ASD) (2016) (0)
- Use of a Direct Observational Measure in a Trial of Risperidone and Parent Training in Children with Pervasive Developmental Disorders (2012) (0)
- Paroxysmal oculogyric dystonia associated with a de novo 3q29 microdeletion. (2020) (0)
- Editorial Preface (2005) (0)
- Activities of Daily Living (2021) (0)
- Atypical Antipsychotics in Pediatric Psychiatry: Efficacy and Tolerability in Well-Designed Trials (2003) (0)
- Focus on Women ’ s mental HealtH Onset and Exacerbation of Obsessive-Compulsive Disorder in Pregnancy and the Postpartum Period (2010) (0)
- Mesoridazine (2021) (0)
- Editorial Preface (2006) (0)
- Sertraline (2019) (0)
- Dopamine (2021) (0)
- Carbamazepine vs. Oxazepam for Benzodiazepine Detoxification in Methadone-Maintained Patients (1993) (0)
- Home Situations Questionnaire--Pervasive Developmental Disorders (2015) (0)
- Brief Report: Social Disability in Autism Spectrum Disorder: Results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network Trials (2012) (0)
- Evaluation and Treatment of New-Onset Psychotic Symptoms in a Patient with Autism Spectrum Disorder and Multiple Autoimmune Disorders. (2021) (0)
- Quetiapine (2021) (0)
- New combination therapy helps children on the autism spectrum learn social skills (2021) (0)
- Psychopharmacology of Adolescents and Adults With Autism Spectrum Disorder (2013) (0)
- Cholinergic System (2021) (0)
- Hyperserotonemia (2021) (0)
- Case Reports: Clozapine for the Treatment of Catatonia in Autism Spectrum Disorder (2021) (0)
- Advanced Pharmacological Approaches to Treating Autism Spectrum Disorders (2010) (0)
- Clinical Correlates of Parenting Stress in Children with Autism Spectrum Disorder and Serious Behavioral Problems (2019) (0)
- What is an animal model ? (2005) (0)
- Fetal Carbamazepine Syndrome (2020) (0)
- Managing Obsessive-Compulsive Patients In Conjunction With the Nonspecialist (1996) (0)
- Atypical Antipsychotics (2021) (0)
- 3.24 REPETITIVE THOUGHTS AND BEHAVIOR IN WILLIAMS SYNDROME (2016) (0)
- Clozapine (2022) (0)
- Treating autism spectrum disorders. Preface. (2008) (0)
- Buspirone for the Treatment of Generalized Anxiety Disorder in Williams Syndrome: A Case Series (2019) (0)
- A Protocol for Sedation Free MRI and PET Imaging in Adults with Autism Spectrum Disorder (2019) (0)
- Editorial Preface (2004) (0)
- A Virtually Delivered Adapted Cognitive-Behavioral Therapy Group for Adults With Williams Syndrome and Anxiety (2022) (0)
- Getting the Word “Out”: A Role for the Motor System in Autism Spectrum Disorder (2019) (0)
- 11. Neuropsychopharmacology of autism-spectrum disorders (1998) (0)
- Input from our Readers (1998) (0)
- Impulsivity in Childhood (2011) (0)
- 6.14 CORRELATES OF BEHAVIORAL DIFFICULTIES IN ADOLESCENTS WITH AUTISM SPECTRUM DISORDER ADMITTED TO INPATIENT PEDIATRIC UNITS (2016) (0)
- Alprazolam (2019) (0)
- 13.4 Psychopharmacology of Behavioral Symptoms in Three Neurogenetic Syndromes Associated With Autism Spectrum Disorder (2017) (0)
- COMMON PSYCHIATRIC COMORBIDITIES IN AUTISM SPECTRUM DISORDER: ADHD, ANXIETY, DEPRESSION, AND CATATONIA (2021) (0)
- Pharmacokinetics (2021) (0)
- ANXIETY DISORDERS IN AUTISM SPECTRUM DISORDER: RECENT RESEARCH AND TREATMENT ADVANCES (2021) (0)
- Thioridazine (2014) (0)
- Repetitive Thoughts and Repetitive Behaviors in Williams Syndrome (2021) (0)
- 1.4 Irritability in Youth with ASD (2022) (0)
- Fluvoxamine Maleate (2021) (0)
- Antidepressant Medications (2021) (0)
- Children’s Yale–Brown Obsessive-Compulsive Scale--Pervasive Developmental Disorders Version (2017) (0)
- Escitalopram (2019) (0)
- A rational pharmacologic approach toward a biologically meaningful subtype of autism spectrum disorder (2020) (0)
- Exploring the Manifestations of Anxiety in Children with Autism Spectrum Disorders (2013) (0)
- NEUROGENETIC SYNDROMES ASSOCIATED WITH AUTISM SPECTRUM DISORDER (2020) (0)
- AN UPDATE ON COMMON COMORBIDITIES IN ASD: SLEEP DISORDERS, ANXIETY, BODY-FOCUSED REPETITIVE BEHAVIORS, AND IRRITABILITY (2022) (0)
- Developmental Right Hemisphere Syndrome (2013) (0)
- Dr. McDougle and Colleagues Reply (2006) (0)
- Repetitive Behavior (2021) (0)
- Behavioral and Pharmacologic Treatment of Aggression in Children With Autism September (2005) (0)
- Challenges and Strategies to Mitigate Problematic Social Media Use in Psychiatric Disorders (2021) (0)
- Psychopharmacology of Autism Spectrum Disorder (2014) (0)
- Patterns in Medication Use for Treatment of Depression in Autistic Spectrum Disorder (2022) (0)
- Brief Report: Major Depressive Disorder with Psychotic Features in Williams Syndrome: A Case Series (2017) (0)
- Knowledge Among Parents of Children Participating in a Randomized Clinical Trial (2005) (0)
- 71.1 SYSTEMIC INFLAMMATION IN ASD (2019) (0)
- Thiothixene (2021) (0)
- Pervasive Developmental Disorders (2009) (0)
- Changes in fundamental frequency in spontaneous speech correlate with cognitive function in Parkinson’s disease A. Glotfelty, W. Katz The Role of Visibility in Silent Speech Tongue Movements: A Kinematic Study of Consonants (2020) (0)
- Predictors and Moderators of Parent Training Efficacy in a Sample of Children with Autism Spectrum Disorders and Serious Behavioral Problems (2011) (0)
- TOWARDS AN IMMUNE (INFLAMMATION)-MEDIATED SUBTYPE OF ASD (2019) (0)
- Prevalence and factors associated with overweight, obesity, and hypertension in a large clinical sample of adults with autism spectrum disorder (2022) (0)
- Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders (2013) (0)
- Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome (2013) (0)
- Nortriptyline (2021) (0)
- Attention Bias to Emotional Faces Varies by IQ and Anxiety in Williams Syndrome (2016) (0)
- Functional Neurological Symptom Disorder in Williams Syndrome: Case series and Review of Relevant Literature. (2021) (0)
- Home Living Skills (2020) (0)
- Related articles (2015) (0)
- Childhood-Onset Schizophrenia (2002) (0)
- Thiothixene Hydrochloride (2020) (0)
- Translational Neuroscience: Historical perspectives on the use of therapeutic agents to treat neurodevelopmental disorders (2012) (0)
- Chlorpromazine (1954) (0)
- Psychopharmacology of Behavioral Symptoms in Three Neurogenetic Syndromes Associated With Autism Spectrum Disorder (2014) (0)
- Paliperidone for irritability in adolescents and young adults with autistic disorder (2012) (0)
- A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder (2011) (0)
- The Use of Antipsychotics in the Treatment of Obsessive‐Compulsive Disorder (2008) (0)
- Multidisciplinary Assessment and Treatment of Self-Injurious Behavior in Autism Spectrum Disorder and Intellectual Disability: Integration of Psychological and Biological Theory and Approach (2014) (0)
- 3.8 Guanfacine for the Treatment of ADHD in Children and Adolescents With Down Syndrome: A Retrospective Chart Review Study (2022) (0)
- Brief Report: Bone Fractures in Children and Adults with Autism Spectrum Disorders (2014) (0)
- Predictive Validity (2022) (0)
- Gonadal Hormones Impart Male-Biased Behavioral Vulnerabilities to Immune Activation via Microglial Mitochondrial Function (2022) (0)
- RESPONSES TO MCPP STIMULATION IN DEPRESSED PATIENTS. AUTHORS' REPLY (1995) (0)
- Acute Tryptophan Depletion A Controlled Case Study in Autistic Disorder (1993) (0)
- 22.2 Parent Description of Anxiety in Angelman Syndrome (2021) (0)
- Brief Report: Pilot Single-Blind Placebo Lead-In Study of Acamprosate in Youth with Autistic Disorder (2013) (0)
This paper list is powered by the following services:
